Literature DB >> 2946870

RNA-protein organization of U1, U5 and U4-U6 small nuclear ribonucleoproteins in HeLa cells.

M N Lelay-Taha, I Reveillaud, J Sri-Widada, C Brunel, P Jeanteur.   

Abstract

Small nuclear ribonucleoproteins (snRNPs) containing U1 and U5 snRNAs from HeLa cells have been fractionated using a combination of isopycnic centrifugation in cesium chloride and ion-exchange chromatography on DEAE-Sepharose. The procedure is based on the extreme stability conferred upon snRNPs by Mg2+ enabling them to withstand the very high ionic strength that prevails in cesium chloride. U1 snRNP prepared by this method contains all nine major proteins (68K, A, B, B', C, D, E, F, G) corresponding to those previously identified by immunoprecipitation and is therefore precipitable by anti-RNP and anti-Sm antibodies. U5 snRNP purified in this way contains the common D to G proteins and is also enriched in a 25 X 10(3) Mr protein that may be U5 snRNP-specific. The core-resistant U5 snRNA sequence (nucleotide 84 to 3' OH) covered by D to G proteins is extended by only six nucleotides. A similar situation is seen in U4-U6 snRNP, which we have obtained in a sufficiently pure form to examine protected sequences. However, the core-resistant sequence of U4 (nucleotide 116 to 3' OH) in U4-U6 snRNP is extended by 37 nucleotides, suggesting that the protein composition of this particle could be more complex than that of U5 snRNP. The ribonucleoprotein organization of snRNPs is summarized and discussed in view of our current knowledge on snRNA sequences protected by proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946870     DOI: 10.1016/0022-2836(86)90321-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  U1-U2 snRNPs interaction induced by an RNA complementary to the 5' end sequence of U1 snRNA.

Authors:  M C Daugeron; J Tazi; P Jeanteur; C Brunel; G Cathala
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

2.  Domain structure of U2 and U4/U6 small nuclear ribonucleoprotein particles from Trypanosoma brucei: identification of trans-spliceosomal specific RNA-protein interactions.

Authors:  A Günzl; M Cross; A Bindereif
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  Reconstitution of functional mammalian U4 small nuclear ribonucleoprotein: Sm protein binding is not essential for splicing in vitro.

Authors:  C Wersig; A Bindereif
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  Purified U5 small nuclear ribonucleoprotein can relieve the inhibition of spliceosome assembly and splicing by snRNP-free nuclear proteins.

Authors:  J Tazi; J Temsamani; C Alibert; W Rhead; S Khellil; G Cathala; C Brunel; P Jeanteur
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

5.  20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition.

Authors:  M Bach; G Winkelmann; R Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Purification of RNA and RNA-protein complexes by an R17 coat protein affinity method.

Authors:  V J Bardwell; M Wickens
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

7.  Evidence for the presence of a small U5-like RNA in active trans-spliceosomes of Trypanosoma brucei.

Authors:  J M Dungan; K P Watkins; N Agabian
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

8.  Trans mRNA splicing in trypanosomes: cloning and analysis of a PRP8-homologous gene from Trypanosoma brucei provides evidence for a U5-analogous RNP.

Authors:  S Lücke; T Klöckner; Z Palfi; M Boshart; A Bindereif
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

9.  U2 small nuclear RNP assembly in vitro.

Authors:  A M Kleinschmidt; J R Patton; T Pederson
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

10.  In vitro splicing of pre-messenger RNA with extracts from 5-fluorouridine-treated cells.

Authors:  J R Patton
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.